These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7617135)

  • 21. Fractional reduction of somatostatin concentration interacted with rat growth hormone releasing hormone to titrate the magnitude of pulsatile growth hormone and prolactin release in perifusion.
    Stachura ME; Tyler JM; Farmer PK
    Neuroendocrinology; 1988 Nov; 48(5):500-6. PubMed ID: 2907614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galanin stimulates immunoreactive growth hormone-releasing factor secretion from rat hypothalamic slices perifused in vitro.
    Kitajima N; Chihara K; Abe H; Okimura Y; Shakutsui S
    Life Sci; 1990; 47(25):2371-6. PubMed ID: 1702174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of somatostatin withdrawal and growth hormone (GH)-releasing factor on GH release in vitro: amount available for release after disinhibition.
    Kraicer J; Cowan JS; Sheppard MS; Lussier B; Moor BC
    Endocrinology; 1986 Nov; 119(5):2047-51. PubMed ID: 2876882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic secretion of somatostatin and growth hormone-releasing factor into the hypophysial-portal circulation is reduced in streptozotocin diabetic male rats.
    Plotsky PM
    Neuroendocrinology; 1991 May; 53(5):433-8. PubMed ID: 1678493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evidence of a positive role for somatostatin to optimize pulsatile growth hormone secretion.
    Turner JP; Tannenbaum GS
    Am J Physiol; 1995 Oct; 269(4 Pt 1):E683-90. PubMed ID: 7485482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of withdrawal of somatostatin and growth hormone (GH)-releasing factor on GH release in vitro.
    Kraicer J; Sheppard MS; Luke J; Lussier B; Moor BC; Cowan JS
    Endocrinology; 1988 May; 122(5):1810-5. PubMed ID: 2896117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal transduction systems in growth hormone-releasing hormone and somatostatin release from perifused rat hypothalamic fragments.
    Cugini CD; Millard WJ; Leidy JW
    Endocrinology; 1991 Sep; 129(3):1355-62. PubMed ID: 1678698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postsomatostatin hypersecretion of growth hormone from perifused rat anterior pituitary cells is dependent on calcium influx.
    McFarlane MB; Bruhn TO; Jackson IM
    Neuroendocrinology; 1993 Mar; 57(3):496-502. PubMed ID: 8100619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia.
    Frohman LA; Downs TR; Clarke IJ; Thomas GB
    J Clin Invest; 1990 Jul; 86(1):17-24. PubMed ID: 1973173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of thyroid hormone deficiency and replacement on rat hypothalamic growth hormone (GH)-releasing hormone gene expression in vivo are mediated by GH.
    Downs TR; Chomczynski P; Frohman LA
    Mol Endocrinol; 1990 Mar; 4(3):402-8. PubMed ID: 2111453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME; Tyler JM; Farmer PK
    Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of glucagon, Neurotensin, and vasoactive intestinal polypeptide on somatostatin release from perifused rat hypothalamus.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1982 Jun; 110(6):2113-7. PubMed ID: 6122561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats.
    Welsh JB; Szabo M
    Endocrinology; 1988 Nov; 123(5):2230-4. PubMed ID: 2901949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone.
    Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P
    Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
    Painson JC; Tannenbaum GS
    Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GHRF causes biphasic stimulation of SRIF secretion from rat hypothalamic cells.
    Richardson S; Twente S; Audhya T
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E829-32. PubMed ID: 2904766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between norepinephrine and serotonin in the neuroendocrine control of growth hormone release in the rat.
    Conway S; Richardson L; Speciale S; Moherek R; Mauceri H; Krulich L
    Endocrinology; 1990 Feb; 126(2):1022-30. PubMed ID: 1688789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine stimulates somatostatin release from perifused hypothalamic cells.
    Richardson SB; Nguyen T; Hollander CS
    Am J Physiol; 1983 Jun; 244(6):E560-6. PubMed ID: 6134472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries.
    Goodyer CG; Branchaud CL; Lefebvre Y
    J Clin Endocrinol Metab; 1993 May; 76(5):1259-64. PubMed ID: 8098715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.